Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

被引：23
|
作者：
Crocq, MA [1 ]
Leclercq, P [1 ]
Guillon, MS [1 ]
Bailey, PE [1 ]
机构：
[1] Ctr Hosp, F-68250 Rouffach, France
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷 / 05期
关键词：
olanzapine; obsessive-compulsive disorder; augmentation therapy; treatment-unresponsive OCD;
D O I：
10.1016/S0924-9338(02)00673-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [41] REFRACTORY OBSESSIVE-COMPULSIVE DISORDER AND ECT
    MALETZKY, B
    MCFARLAND, B
    BURT, A
    CONVULSIVE THERAPY, 1994, 10 (01): : 34 - 42
  • [42] Open trial of flutamide for treatment of obsessive-compulsive disorder
    Altemus, M
    Greenberg, BD
    Keuler, D
    Jacobson, KR
    Murphy, DL
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (07) : 442 - 445
  • [43] Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
    Feusner, Jamie D.
    Kerwin, Lauren
    Saxena, Sanjaya
    Bystritsky, Alexander
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 81 - 93
  • [44] Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study
    Francobandiera, G
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (04): : 356 - 358
  • [45] Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial
    Bogetto, F
    Bellino, S
    Vaschetto, P
    Ziero, S
    PSYCHIATRY RESEARCH, 2000, 96 (02) : 91 - 98
  • [46] Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
    Dougherty, Darin D.
    Jameson, Mariko
    Deckersbach, Thilo
    Loh, Rebecca
    Thompson-Hollands, Johanna
    Jenike, Michael
    Keuthen, Nancy J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (06) : 306 - 311
  • [47] Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study
    Marazziti, D
    Pfanner, C
    Dell'Osso, B
    Ciappareli, A
    Presta, S
    Corretti, G
    Di Nasso, E
    Mungai, F
    Dell'Osso, L
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) : 392 - 394
  • [48] Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients
    Bejerot, Susanne
    Stein, Sofia Sigra
    Welin, Elisabet
    Eklund, Daniel
    Hylen, Ulrika
    Humble, Mats B.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 158 : 319 - 329
  • [49] Treatment of obsessive-compulsive disorder
    Dar, R
    CURRENT OPINION IN PSYCHIATRY, 1996, 9 (02) : 125 - 128
  • [50] Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder
    Saxena, S
    Wang, D
    Bystritsky, A
    Baxter, LR
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (07) : 303 - 306
12345